v3.24.1.1.u2
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Revenues:
Expenses:    
Research and development 235,359 201,398
General and administrative 539,458 428,326
Total expenses 774,817 629,724
Loss from operations (774,817) (629,724)
Other income:    
Interest income 90,106 90,128
Net loss $ (684,711) $ (539,596)
Basic net loss per share $ (0.00) $ (0.00)
Diluted net loss per share $ (0.00) $ (0.00)
Weighted average common stock shares outstanding - basic 172,079,589 171,793,134
Weighted average common stock shares outstanding - diluted 172,079,589 171,793,134

Source